Top Markets
Coin of the day
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Classement en actions #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Prix de l'action
$0.1502
Dernière synchronisation: 2024-11-04
Capitalisation boursière
$6.43M
Changement (1 jour)
-5.45%
Changement (1 an)
0.00%
Pays
US
Échange Renalytix Plc (RNLX)

Catégorie

EPS pour Renalytix Plc (RNLX)
EPS au September 2024 TTM : $-0.52
Selon les derniers rapports financiers et le cours de l'action de Renalytix Plc, l’EPS actuel de la société (TTM) est de $-0.52. À la fin de 2023, la société avait un EPS de $-1.10 une diminution par rapport à celui de 2022, qui était de $-1.24.
Historique de l'EPS de Renalytix Plc de 2018 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-0.52 -16.13%
2024 $-0.62 -43.64%
2023 $-1.10 -11.29%
2022 $-1.24 26.53%
2021 $-0.98 188.24%
2020 $-0.34 -82.83%
2019 $-1.98 3,200.00%
2018 $-0.06 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$3.48 -769.23%
US
$1.50 -388.62%
AU
$1.43 -375.00%
US
$-1.43 175.00%
US
- -
US